Disposition of 200 shares by University Of Texastexas Am Investment Management Co of Aileron Therapeutics at 4.275 subject to Rule 16b-3

ALRNDelisted Stock  USD 2.11  0.15  7.65%   
About 55% of Aileron Therapeutics' investors are presently thinking to get in. The analysis of current outlook of investing in Aileron Therapeutics suggests that some traders are interested regarding Aileron Therapeutics' prospects. Aileron Therapeutics' investing sentiment overview a quick insight into current market opportunities from investing in Aileron Therapeutics. Many technical investors use Aileron Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Aileron Therapeutics 10 Percent Owner. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Read at macroaxis.com
Disposition of 200 common stock at 4.275 of Aileron Therapeutics by University Of Texas/texas Am Investment Management Co on 14th of May 2024. This event was filed by Aileron Therapeutics with SEC on 2024-05-01. SEC Form: Changes in beneficial ownership

Aileron Therapeutics Fundamental Analysis

We analyze Aileron Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aileron Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aileron Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Short Ratio

Short Ratio Comparative Analysis

Aileron Therapeutics is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Aileron Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aileron Therapeutics stock to make a market-neutral strategy. Peer analysis of Aileron Therapeutics could also be used in its relative valuation, which is a method of valuing Aileron Therapeutics by comparing valuation metrics with similar companies.

Peers

Aileron Therapeutics Related Equities

CRISCuris   3.46   
0%
50.0%
SLRXSalarius Pharmaceuticals   2.67   
0%
38.0%
ARTLArtelo Biosciences   0.88   
0%
12.0%
ASMBAssembly Biosciences   0.49   
0%
7.0%
ABVCABVC Biopharma     
0%
1.0%
BPTHBio Path     
1.0%
0%
CTMXCytomX Therapeutics     
1.0%
0%
SABSSAB Biotherapeutics   0.84   
12.0%
0%
GOVXGeoVax Labs   0.89   
12.0%
0%
NUVBNuvation Bio   1.18   
17.0%
0%
TILInstil Bio   2.10   
30.0%
0%
BNTCBenitec Biopharma   6.87   
100.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Consideration for investing in Aileron Stock

If you are still planning to invest in Aileron Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aileron Therapeutics' history and understand the potential risks before investing.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Valuation
Check real value of public entities based on technical and fundamental data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine